Operational characteristics of continuous renal replacement modalities used for critically ill patients with acute kidney injury

International Journal of Artificial Organs

Volumn 31, Issue 6, 2008, Pages 525-534

  Huang, Z ^a   Letteri, J J ^b   Clark, William R ^b,c,f   Ronco, C ^d   Gao, D ^e  

^a WIDENER UNIVERSITY   (United States)

^b Gambro   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SAN BORTOLO HOSPITAL   (Italy)

^e UNIVERSITY OF WASHINGTON   (United States)

^f Gambro Inc ^*  (United States)

Author keywords

Clearance; Convection; Diffusion; Hemodialysis; Hemofiltration; Sieving coefficient

Indexed keywords

DIFFUSION IN LIQUIDS; INTENSIVE CARE UNITS; PATIENT TREATMENT;

CLEARANCE; CONVECTION; CRITICALLY-ILL PATIENTS; GLOMERULAR FILTRATION; HAEMODIALYSIS; HEMOFILTRATION; OPERATIONAL CHARACTERISTICS; RENAL REPLACEMENT THERAPIES; SIEVING COEFFICIENT; SOLUTE TRANSFER;

DIALYSIS;

ADSORPTION; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; DIALYSATE; DIFFUSION; GLOMERULUS FILTRATION; HEMODIALYSIS; HEMODILUTION; HUMAN; INTENSIVE CARE; INTERMETHOD COMPARISON; KIDNEY CLEARANCE; KIDNEY FUNCTION; KIDNEY INJURY; REVIEW; SOLUTE; SURVIVAL RATE; THERMODYNAMICS; URINARY EXCRETION; WATER PERMEABILITY;

EID: 49649110139     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803100608     Document Type: Review

References (30)

1. Clark WR, Henderson LW. Renal vs continuous vs intermittent therapies for removal of uremic toxins. Kidney Int 2001; 59 (Suppl 78): S298-303.
2. Colton CK, Henderson LW, Ford C, Lysaght MJ. Kinetics of hemodiafiltration: Part I: in vitro transport characteristics of a hollow-fiber blood ultrafilter. J Lab Clin Med 1975; 85: 355-71.
3. Huang Z, Letteri JJ, Clark WR, Zhang W, Gao D, Ronco C. Ultrafiltration rate as dose surrogate in pre-dilution hemofiltration. Int J Artif Organs 2007; 30: 124-32.
4. Clark WR, Macias WL, Molitoris BA, Wang NH. Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int 1995; 48: 481-7.
5. Clark WR, Ronco C. Continuous renal replacement techniques. Contrib Nephrol 2004; 144: 264-77.
6. Clark WR, Ronco C. Determinants of hemodialyzer performance and the effect on clinical outcome. Nephrol Dial Transplant 2001; 16 (Suppl 3): S56-60.
7. Clark WR, Hamburger RJ, Lysaght MJ.. Effect of membrane composition and structure on performance and biocompatibility in hemodialysis. Kidney Int 1999; 56: 2005-15.
8. Henderson LW. Biophysics of ultrafiltration and hemofiltration. In: Dortdrecht JC, ed. Replacement of renal function by dialysis (4th edn). Boston, MA: Kluwer Academic, 1996; 114-8.
9. Clark WR, Macias WL, Molitoris BA, Wang NH. β2-Microglobulin membrane adsorption: equilibrium and kinetic characterization. Kidney Int 1994; 46: 1140-6.
10. Clark WR. Quantitative characterization of hemodialyzer solute and water transport. Semin Dial 2001; 14: 32-6.
11. Kim S. Characteristics of protein removal in hemodiafiltration. Contrib Nephrol 1994; 108: 23-37.
12. Ronco C, Bellomo R, Hommel P, Brendolan A, Dan M, Piccinni P, LaGreca G. Effects of different doses in continuous veno-venous hemofiltration on outcomes in acute renal failure: a prospective, randomized trial. Lancet 2000; 355: 26-30.
13. Huang Z, Gao D, Clark WR. Convective renal replacement therapies for acute renal failure and end-stage renal disease. Hemodial Int 2004; 8: 386-93.
14. Clark WR, Turk JE, Kraus MA, Gao D. Dose determinants in continuous renal replacement therapy. Int J Artif Organs 2003; 27: 815-20.
15. Venkataraman R, Kellum JA, Palevsky P. Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States. J Crit Care 2002; 17: 246-50.
16. Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006; 70: 1312-7.
17. Troyanov S, Cardinal J, Geadah D, Parent D, Courteau S, Caron S, Leblanc M. Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters. Nephrol Dial Transplant 2003; 18: 961-6.
18. Bonnardeaux A, Pichette V, Ouimet D, Geadeh D, Habel F, Cardinal J. Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis. Am J Kidney Dis 1992; 19: 31-8.
19. Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999; 34: 486-92.
20. Salvatori G, Ricci Z, Bonello M, Ratanarat R, D'Intini V, Brendolan A, Dan M, Piccinni P, Bellomo R, Ronco C. First clinical trial for a new CRRT machine: the Prismaflex. Int J Artif Organs 2004; 27: 404-9.
21. Liao Z, Zhang W, Poh CK, Huang Z, Hardy PA, Kraus MA, Clark WR, Gao D. Kinetic comparison of different acute dialysis therapies. Artif Organs 2003; 27: 802-7.
22. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346: 305-10.
23. Kumar VA, Craig M, Depner TA, Yeun JY. Extended daily dialysis: a new approach to renal replacement therapy in the intensive care unit. Am J Kidney Dis 2000; 36: 294-300.
24. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 2001; 60: 777-85.
25. Clark WR, Leypoldt JK, Henderson LW, Mueller BA, Scott MK, Vonesh EF, Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model. J Am Soc Nephrol 1999; 10: 601-10.
26. Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H, Fliser D. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 2004; 43: 342-9.
27. Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol. Epub 2008 Mar 12.
28. The VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359. Epub 2008 May 20.
29. Faulhaber-Walter R, Hafer C, Jahr N, Vahlbruch J, Haller H, Fliser D, Kielstein J. The Hannover-Dialysis-Outcome (HAND-OUT) Study: comparison of standard versus intensified extended daily dialysis in treatment of patients with septic acute renal failure on the intensive-care unit [abstract]. European Dialysis and Transplant Association Annual Congress, Barcelona, Spain. 2007.
30. Ricci Z, Ronco C, Bachetoni A, D'Amico G, Rossi S, Alessandri E, Rocco M, Pietropaoli P. Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion. Crit Care 2006; 10: R67.